FDA — authorised 12 September 2008
- Application: NDA022285
- Marketing authorisation holder: UCB INC
- Local brand name: KEPPRA XR
- Indication: TABLET, EXTENDED RELEASE — ORAL
- Status: approved
🇺🇸 Keppra XR (Levetiracetam XR) in United States
FDA authorised Keppra XR (Levetiracetam XR) on 12 September 2008
Marketing authorisation
Other Neurology approved in United States
Frequently asked questions
Is Keppra XR (Levetiracetam XR) approved in United States?
Yes. FDA authorised it on 12 September 2008.
Who is the marketing authorisation holder for Keppra XR (Levetiracetam XR) in United States?
UCB INC holds the US marketing authorisation.